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Promethazine-chlorpromazine Combination in the
Treatment of Unmanageable Psychotic Patients
A r m a n d o R . Favazza, M . D . *

Administering a combination of promethazine and chlorpromazine to patients with
a "galloping psychosis" has an antipsychotic and tranquilizing effect which calms
them down to a more manageable and less aggressive state. The drugs are
chemically similar; promethazine's actions are strongly potentiated in the combination, so large doses must be given under careful supervision. Case histories
demonstrate successful short term management of acutely psychotic,
aggressive
patients who were a danger to themselves and others.

Acute, intense psychotic episodes
can pose difficult problems for both
the patient and those who care for him.
Use of trifluoperazine may aggravate
such patients, while thioridazine and
haloperidol cannot be given parenterally. Most commonly used drug in treating such patients is chlorpromazine;
because of its great ability to calm patients, its relative safety in large doses,
its availability in both oral and parenteral forms, and also because most
physicians are familiar with it.
While most patients can be brought
under rapid control with chlorpromazine alone, there are some who seem
to resist this treatment. It is not un-

common in the author's experience for
some patients to receive massive doses
(up to 3 grams a day) and yet remain
psychotic and unmanageable. During
these episodes of "galloping psychosis"
patients may be abusive to themselves
and others, unable to follow orders, to
eat or rest, and frightening to other
patients. In the past such patients who
were obviously out of control were
placed in seclusion rooms and/or
given electroshock. In many institutions, however, electroshock is not frequently resorted to, and seclusion
rooms have been abandoned in favor
of a combination of a better trained
and more abundant staff, a well conceived milieu, and modern drugs. But
when the usual drugs and milieu fail,
even the best trained staff may have
difficulty handling patients in whom a
psychotic process rages unabated. For
such patients the author has found ef-
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fective a combination of promethazine
(Phenergan) and chlorpromazine.
The chlorpromazine is used for its
anti-psychotic and tranquilizing effects.
Whether chlorpromazine affects symptoms alone or has a direct effect on
some psychotic processes, it appears to
be beneficial in causing these chaotic
episodes to abate. The physician certainly would be remiss to withhold the
drug or another like it.
Promethazine, marketed primarily
as an anti-histaminic, is used because
of its ability to slow down the patient
rapidly so that he can be cared for.
The manufacturer's package insert
notes that promethazine "relieves apprehension and produces a light sleep
from which a patient can be easily
aroused" (the manufacturer specifically notes this is conjunction with
nighttime surgical or obstetrical sedation).
Promethazine is a phenothiazine derivative and is chemically similar to
chlorpromazine. (See below.)

PROMETHAZINE
HYDROCHLORIDE

Laborit, the French surgeon, attracted great attention to the drug in
the early 1950's with his papers on its
use in artificial hibernation.! •^' The
drug has also been widely used in sleep
therapy.* " For psychiatric use promethazine has not been found to be as
effective as the other phenothiazines^
despite some early enthusiasm.'' In
1958 Shea et aP wrote:
"The data suggests that promethazine
unlike other phenothiazine derivatives
when administered intravenously in
relatively large concentrations may induce a depression of both cortical and
subcortical centers. In view of this action the drug would seem to have considerable therapeutic value in the management of those patients with increased psychomotor activity not clinically controlled by either promazine
or chlorpromazine."
Promethazine's actions are strongly
potentiated when administered with
chlorpromazine. In moderate doses it
makes a patient feel fatigued or sleepy
and greatly slows him down. In large
doses it can put a patient to sleep. It
is possible to regulate the medication
so that a patient achieves a light sleep
from which he can be awakened easily
to eat, drink, void, breathe deeply and
take short walks. The state of sleep
can be so regulated that the patient
will respond to questions so that the
progression or diminution of the psychotic episode can be roughly gaged.
One or two doses of promethazine can
be withheld if the patient is sleeping
so deeply as to make evaluation of his
mental state impossible. Barbituates,
because of their depressing effect on
medullary centers and their tendency
to induce deep sleep, are not satisfactory substitutes for promethazine.

CHLORPROMAZINE
HYDROCHLORIDE
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A typical six-hour period is charted:

Case Reports
The following cases demonstrate the
combined use of promethazine and
chlorpromazine.

CHART NUMBER ONE
HOURS
8 A.M.
Blood Pressure

110/80

Case Number 1

Chlorpromazine

300 r^g

The patient was a 17-year-old girl who
first became psychotic while visiting a foreign country as an exchange student. She
was immediately flown back home and admitted directly to University Hospital. After
appearing to restitute, for no discernible
reason, she became progressively and severely psychotic. For 36 hours she did not
sit down or eat. She was unable to follow orders. She talked loudly about natural
and supernatural spirits, the purity of her
blood, and the secrets of the universe which
she alone understood. She carried a hairbrush and hit anyone near her. She rushed
into the nursing station several times attempting to rip the phone out of the wall.
The other patients became frightened and
relayed their anxiety to the staff. As fairly
standard procedure the patient received 50
mgs of intramuscular chlorpromazine for
three doses, 30 minutes apart. This had no
effect except that she finally agreed to take
oral medication rather than be held down
for an injection. She then received hourly
doses of medication, but seemed unaffected
by the high dose of 2500 mgs in 24 hours.
Her blood pressure and physical state were
closely monitored. Her psychosis appeared
to worsen. The addition of 20 mgs of trifluoperazine only seemed to heighten her
agitation. Finally, after 500 mgs of a barbituate was given intramuscularly, the patient fell asleep.
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The patient was maintained in this state
for 10 days. On several occasions she refused to take her medications orally and
they were then given intramuscularly. Her
room door was kept open at all times and,
while other patients could look in, they
were not allowed to visit. Her treatment
was discussed at the patient-staff conference.
A nurse, aide or physician checked the patient every 30 minutes, and her mental
status was roughly evaluated by the physician several times daily. Even while she
was under the influence of all these medications, it was possible to determine easily
at the end of 10 days that her psychosis
was lessening. Her medication was reduced
by one-half for a four-day period, then by
one-half again for four more days. Finally
the promethazine and trihexyphenidyl were
eliminated and the patient continued on
low doses of chlorpromazine.

In six hours, she awoke, and if anything,
she was more unmanageable. All attempts
by staff to handle her failed. Finally she
was started on a regimen of 50 mgs promethazine orally every four hours and 300
mgs chlorpromazine orally every four hours.
The doses were so administered that she
received one medication or the other every
two hours. Before each dose her physical
and mental status were evaluated. She also
received eight mgs of trihexyphenidyl (Artane) daily. Within several hours the patient went into a light sleep. She could be
aroused easily. She was able to eat and to
void. With help she could walk to the bathroom and even brush her teeth. A nursing
chart was set up and faithfully maintained.

Case Number 2
The patient was a 43-year-old male with
a long history of mental illness. He had
received ECT 20 years ago and insulin
shock therapy six years ago. Eight months
previously he was diagnosed as a manicdepressive at a state mental hospital and
was treated with massive doses of chlorpromazine (2500 mg a day) for his "mania."
At this time he was quite paranoid and
was threatening people with an axe. He
presented a serious management problem
for three months until he appeared to "set-
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siderations after being placed on the
medication. The medication made it
possible for the staff to care for the
patient better and for the patient herself to weather her psychosis better.
Because other patients on the ward
became apprehensive, and some had
fantasies about being punished should
they begin to "act up" keeping the
door open to the patient's room and
discussing the treatment at the patientstaff conference served to allay their
anxiety.
In the second case the addition of
promethazine appeared to decrease the
patient's ability to act upon his hostile
feelings. He felt sleepy, groggy and
weak at times but was able to stay
awake and eventually engage in socialization. It should be mentioned that
(perhaps because of its military associations) the V. A. hospital milieu generally serves to decrease aggressive behavior in rapid fashion. The patient
described is well remembered by the
staff as being an especially difficult patient in whom chemical restraint was
a necessity.

tie down." Three months after discharge he
was admitted to the Ann Arbor Veterans
Hospital where he was diagnosed as having
a schizo-affective disorder. He was admitted
by court order after two psychiatrists found
him to be dangerous to himself and others.
In the hospital he talked confusedly about
religion and about wanting to be the president of the United States. His son had been
killed in Vietnam two weeks previously.
The patient felt that machines were influencing his mind and that he had to kill
"some people." He refused to take any medication. He carried a pool cue and hit several patients who tried to talk with him.
He was forcibly given 100 mg of intramuscular chlorpromazine. Four hours later,
still severely agitated and hostile, he was
given another 100 mg intramuscularly.
There was little change in symptoms. He
raged through most of the night except for
a few brief naps.
The next morning he was as hostile as
ever and struck several patients. He finally
agreed to take oral medication when told
he would be given more intramuscular
medication by force. He was started on
Q.I.D. oral doses of 200 mg chlorpromazine and 75 mg promethazine. After two
doses he felt somewhat drowsy, and still
refused to cooperate but did not strike anyone. That night he was more responsive to
verbal orders and, while still hostile, was
more easily approachable. He developed
mild extra-pyramidal signs and was given
benztrozine (Cogentin) 2 mg orally B.I.D.
With each passing day he became easier
to approach. Two days later he agreed to
attend group therapy. Within a week he
was much calmer, cooperative and not very
aggressive. His medication was reduced to
chlorpromazine 50 mg and promethazine 50
mg, both Q.I.D. Four weeks after admission he was given a two-week leave of absence on the medication. When he was discharged from the hospital, he continued
with both drugs. He is being followed in
the outpatient clinic every two weeks and
his medication has been continued. There
has been no evidence of neurological side
effects. Liver function and other chemical
tests have been normal.

Although combination of promethazine and chlorpromazine has been
mentioned in the psychiatric literature
rather infrequently,
" the author
discovered that the combination has
been used, and is currently being used,
by psychiatrists at the Ypsilanti State
Hospital and the Ann Arbor Veterans
Hospital. In personal communications
from psychiatrists in those two hospitals, the author was informed that
the combination is being used for aggressive, difficult to manage psychotic
patients when chlorpromazine (2000
mg orally or its equivalent) alone was
not effective. These psychiatrists reported using the combination also in

Comment
It must be emphasized that in the
first case, the medication was not
given simply to make it easier for the
staff. She received very close staff con308
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come abnormal.
The doses of both drugs greatly exceed the doses recommended in the
manufacturers' direction circulars.
They must be administered with care.
The promethazine - chlorpromazine
combination is evidently in fairly common use and would appear to be helpful in the short term management of
the acutely psychotic, aggressive patient.

hospitals in Kansas, Iowa and Europe.
A check of 10 patient histories, in
which the combination was mentioned,
showed that nine patients were rendered more manageable and less aggressive. The usual oral doses of medication were 200 mgs chlorpromazine
Q.I.D. and 25 mgs promethazine
Q.I.D. An anti-parkinsonian drug was
usually needed. In no patients did liver
function or other chemical tests be-

REFERENCES

1. Laborit, H., and Huguenard, P.: L'hibernation artificielle chez le grand choque. Presse Med
61:1029-30, 18 Jul 1953.
2. Laborit, H.: De la neuroplegic a ^hibernation artificielle. Gaz Med France 59:1423-8, Dec
1952.
3. Laborit, H.; Jaulmes, C, and Benitte, A.: Quelque aspects experimentaux de l'hibernation
artificielle. Anesth Analg (Paris) 9:232-9, Jun 1952.
4. Schultz, J.D.; Fazekas, J.F., and Shea, J.G.: Phenergan in prolonged sleep therapy. Paper
presented at the 113th annual meeting, American Psychiatric Association, Chicago,
13-17 May 1957.
5. Ratshow, M . : Der Heilschlap mit Phenothiazin-Derivaten (Atosil und Megaphen).
Medizinische, 17 Oct 1953, pp 1351-4.
6. Linke, H.: Sleep therapy in internal medicine. Aerztl Forsch 15:53-62, 10 Feb 1961.
7. Samuels, A.S.: Phenergan in treatment of psychiatric patients. Dis Nervous Syst 18:183-8,
May 1957.
8. Erwin, H.J.: Clinical observations on the use of promethazine-hydrochloride in psychiatric
disorders. Amer J Psych 113:783-7, Mar 1957.

309

Favazza
9. Shea, J.G., et al: The clinical and cerebral action of promethazine and methylphenidate
hydrochloride. Amer J Medical Sci 235:201-5, Feb 1958.
10. Shorvon H.J.: Drug therapy in psychiatry. Practitioner 175:161-9, Aug 1955.
11. D'errico, A.; MoreUo, G., and Turchiaro, G.: Sull' impiego dell' associazione cholopromazine-prometazafenobarbitale in psichiatria. Studio clinico di 60 casi. Minerva Med 57270-4, 27 Jan 1966.

310

